| Literature DB >> 35682079 |
Jorge Quintas1, Ana Guerreiro1,2, Maria João Leote de Carvalho3,4, Vera Duarte2,4, Ana Rita Pedro5,6, Ana Filipa Gama5,6, Inês Keygnaert7,8, Sónia Dias5,6.
Abstract
The social conditions created by the COVID-19 pandemic had a great potential to affect the mental health of individuals. Meta-analyses indicate a rise in these problems in these periods among general populations, patients and health professionals, even with substantial heterogeneous results. This paper examines mental health impacts specifically during the first wave of COVID-19. An online survey was conducted with a Portuguese convenience sample (N = 1.062) comprising questions about substance use, perceived stress, post-traumatic stress disorder and self-damage behaviors. The results concerning substance use show an extensive use of medication to sleep or calm down, especially among women and older respondents, a small percentage of alcohol consumers with a high pattern of use and less frequent cannabis consumption, even with a quarter of users who began only in the COVID-19 period. The rates of perceived stress and PTSD were higher compared with international prevalence estimations during the pandemic conditions. Both correlated measures were worse for women and young people. Another problematic issue was the rate of suicidal ideation, with a relevant proportion of starters during this period. These data reinforce the need to promote access to mental health services.Entities:
Keywords: COVID-19; lockdown; mental health; psychological impact; public health
Mesh:
Year: 2022 PMID: 35682079 PMCID: PMC9180313 DOI: 10.3390/ijerph19116489
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Substance use during the first wave of COVID-19.
| Total | |
|---|---|
| Alcohol consumption in a day ( | |
| Yes, during the last 4 weeks | 591 (55.6) |
| 1 or 2 cups | 468 (79.2) |
| 3 or 4 cups | 93 (15.7) |
| 5 or more cups | 30 (5.1) |
| Consumption of medication to sleep or calm down ( | |
| Yes, in lifetime | 288 (33.3) |
| Yes, during the last 4 weeks | 123 (42.7) |
| Yes, only during the last 4 weeks | 100 (34.7) |
| Consumption of cannabis ( | |
| Yes, in lifetime | 68 (8.4) |
| Yes, during the last 4 weeks | 25 (36.8) |
| Yes, only during the last 4 weeks | 18 (26.5) |
| Consumption of cocaine, amphetamines, ecstasy, heroin or other drugs ( | |
| Yes, in lifetime | 9 (1.1) |
| Yes, during the last 4 weeks | 3 (33.3) |
| Yes, only during the last 4 weeks | 3 (33.3) |
Post-traumatic stress disorder during the first wave of COVID-19.
| Total | |
|---|---|
| PC-PTSD-5 ( | Yes |
| Had nightmares about the event(s) or thought about the event(s) when you did not want to ( | 346 (40.8) |
| Tried hard not to think about the event(s) or went out of your way to avoid situations that reminded you of the event(s) ( | 394 (46.6) |
| Been constantly on guard, watchful, or easily startled ( | 232 (27.6) |
| Felt numb or detached from people, activities, or your surroundings ( | 294 (34.8) |
| Felt guilty or unable to stop blaming yourself or others for the event(s) or any problems the event(s) may have caused ( | 231 (27.4) |
| PC-PTSD-5 Total score (M = SD) | 1.76 (1.61) |
| PC-PTSD-5 Level | |
| 0 | 251 (30.2) |
| 1 | 172 (20.7) |
| 2 | 145 (17.5) |
| 3 | 112 (13.5) |
| 4 | 89 (10.7) |
| 5 | 61 (7.3) |
Perceived stress during the first wave of COVID-19.
| Total | |
|---|---|
| PSS 10 ( | 17.25 (6.31) |
| PSS 10 level | |
| Low | 228 (27.9) |
| Moderate | 531 (65.0) |
| High | 58 (7.1) |
Suicidal ideation, suicide attempts and self-inflicted damage during the first wave of COVID-19.
| Total | |
|---|---|
| Suicidal ideation ( | |
| Yes, in lifetime | 148 (17.8) |
| Yes, in last 4 weeks | 33 (22.3) |
| Yes, only in last 4 weeks | 22 (14.9) |
| Suicide attempt ( | |
| Yes, in lifetime | 20 (8.4) |
| Yes, in last 4 weeks | 0 |
| Yes, only in last 4 weeks | 0 |
| Self-inflicted damage ( | |
| Yes, in lifetime | 37 (5.1) |
| Yes, in last 4 weeks | 4 (10.8) |
| Yes, only in last 4 weeks | 3 (8.1) |